Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$68.06
-4.2%
$74.96
$60.09
$86.20
$13.48B0.63,663 shs9,228 shs
Getinge stock logo
GNGBY
Getinge
$20.40
+1.4%
$20.63
$18.70
$24.67
$5.48B0.972,759 shs1,343 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$253.99
-1.6%
$269.03
$239.67
$293.72
$21.16B0.91758,588 shs581,280 shs
Viatris Inc. stock logo
VTRS
Viatris
$17.17
-1.3%
$14.21
$8.19
$17.53
$20.25B0.8812.17 million shs20.24 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.00%+5.33%-4.26%-10.03%+7.93%
Getinge stock logo
GNGBY
Getinge
0.00%+0.27%-2.75%-10.97%+7.20%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.00%+0.27%-6.37%-7.20%+4.66%
Viatris Inc. stock logo
VTRS
Viatris
0.00%+16.40%+28.15%+19.27%+101.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$68.06
-4.2%
$74.96
$60.09
$86.20
$13.48B0.63,663 shs9,228 shs
Getinge stock logo
GNGBY
Getinge
$20.40
+1.4%
$20.63
$18.70
$24.67
$5.48B0.972,759 shs1,343 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$253.99
-1.6%
$269.03
$239.67
$293.72
$21.16B0.91758,588 shs581,280 shs
Viatris Inc. stock logo
VTRS
Viatris
$17.17
-1.3%
$14.21
$8.19
$17.53
$20.25B0.8812.17 million shs20.24 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.00%+5.33%-4.26%-10.03%+7.93%
Getinge stock logo
GNGBY
Getinge
0.00%+0.27%-2.75%-10.97%+7.20%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.00%+0.27%-6.37%-7.20%+4.66%
Viatris Inc. stock logo
VTRS
Viatris
0.00%+16.40%+28.15%+19.27%+101.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eurofins Scient stock logo
ERFSF
Eurofins Scient
2.33
HoldN/AN/A
Getinge stock logo
GNGBY
Getinge
2.33
HoldN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.73
Moderate Buy$308.0021.26% Upside
Viatris Inc. stock logo
VTRS
Viatris
2.38
Hold$15.71-8.48% Downside

Current Analyst Ratings Breakdown

Latest GNGBY, LH, VTRS, and ERFSF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Viatris Inc. stock logo
VTRS
Viatris
Boost Price TargetBuy$18.00 ➝ $20.00
5/8/2026
Viatris Inc. stock logo
VTRS
Viatris
Boost Price TargetNeutral$17.00 ➝ $18.00
5/1/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Set Price Target$334.00
4/23/2026
Getinge stock logo
GNGBY
Getinge
UpgradeHold
4/8/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Reiterated RatingOutperform$300.00
3/27/2026
Viatris Inc. stock logo
VTRS
Viatris
Reiterated RatingSell (D)
3/24/2026
Viatris Inc. stock logo
VTRS
Viatris
Boost Price TargetOverweight$15.00 ➝ $17.00
2/24/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetNeutral$270.00 ➝ $300.00
2/18/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetOverweight$319.00 ➝ $330.00
2/18/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetOutperform$313.00 ➝ $326.00
2/17/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Reiterated RatingOverweight
(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$8.25B1.56$6.90 per share9.86$30.19 per share2.25
Getinge stock logo
GNGBY
Getinge
$3.57B1.55$2.03 per share10.07$11.07 per share1.84
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.95B1.49$24.45 per share10.39$106.45 per share2.39
Viatris Inc. stock logo
VTRS
Viatris
$14.30B1.40$7.28 per share2.36$12.59 per share1.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$537.29MN/AN/AN/AN/AN/AN/AN/AN/A
Getinge stock logo
GNGBY
Getinge
$230.87M$0.9222.1714.78N/A6.92%10.39%5.38%7/17/2026 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$876.50M$11.2922.5013.111.816.66%16.29%7.62%7/23/2026 (Estimated)
Viatris Inc. stock logo
VTRS
Viatris
-$3.51B-$0.26N/A6.581.65-2.04%19.04%7.62%N/A

Latest GNGBY, LH, VTRS, and ERFSF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Viatris Inc. stock logo
VTRS
Viatris
$0.52$0.59+$0.07$0.15$3.36 billion$3.52 billion
4/30/2026Q1 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.09$4.25+$0.16$3.35$3.51 billion$3.54 billion
2/26/2026Q4 2025
Viatris Inc. stock logo
VTRS
Viatris
$0.53$0.57+$0.04-$0.30$3.51 billion$3.70 billion
2/17/2026Q4 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$3.95$4.07+$0.12$1.98$3.56 billion$3.52 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/AN/AN/A
Getinge stock logo
GNGBY
Getinge
$0.291.42%N/A31.52%N/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.881.13%N/A25.51%N/A
Viatris Inc. stock logo
VTRS
Viatris
$0.482.80%N/AN/A N/A

Latest GNGBY, LH, VTRS, and ERFSF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/4/2026
Viatris Inc. stock logo
VTRS
Viatris
quarterly$0.123.09%5/22/20265/22/20266/17/2026
4/9/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.05%5/29/20265/29/20266/11/2026
2/23/2026
Viatris Inc. stock logo
VTRS
Viatris
quarterly$0.123.38%3/9/20263/9/20263/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/A
Getinge stock logo
GNGBY
Getinge
0.27
1.32
0.86
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.68
1.73
1.54
Viatris Inc. stock logo
VTRS
Viatris
0.85
1.60
0.82

Institutional Ownership

CompanyInstitutional Ownership
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Getinge stock logo
GNGBY
Getinge
N/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Viatris Inc. stock logo
VTRS
Viatris
79.88%

Insider Ownership

CompanyInsider Ownership
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Getinge stock logo
GNGBY
Getinge
N/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Viatris Inc. stock logo
VTRS
Viatris
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eurofins Scient stock logo
ERFSF
Eurofins Scient
62,696189.62 millionN/ANot Optionable
Getinge stock logo
GNGBY
Getinge
11,791272.37 millionN/ANot Optionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
71,00082.00 million81.31 millionOptionable
Viatris Inc. stock logo
VTRS
Viatris
30,0001.16 billion1.16 billionOptionable

Recent News About These Companies

Viatris rises as Q1 beat indicates growth momentum
Viatris Inc. (VTRS) Q1 2026 Earnings Call Transcript
Viatris Reports First-Quarter 2026 Financial Results
Viatris Names Paul Campbell Interim Chief Financial Officer
Viatris Announces Quarterly Dividend

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eurofins Scient stock logo

Eurofins Scient OTCMKTS:ERFSF

$68.06 -3.00 (-4.22%)
As of 05/8/2026 03:32 PM Eastern

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Getinge stock logo

Getinge OTCMKTS:GNGBY

$20.40 +0.28 (+1.39%)
As of 05/8/2026 12:03 PM Eastern

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Labcorp stock logo

Labcorp NYSE:LH

$253.99 -4.06 (-1.57%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$254.13 +0.14 (+0.06%)
As of 05/8/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Viatris stock logo

Viatris NASDAQ:VTRS

$17.17 -0.22 (-1.27%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$16.98 -0.20 (-1.14%)
As of 05/8/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.